Invion Ltd has released a press release.
Appendix 4C - March 2018 quarter
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Invion alliance with Hudson Institute of Medical Research
- Completion iof Rights Issue
- Appendix 4D and Financial Report for half year to 31 Dec 17
- Rights Issue Information Booklet
- Appendix 4C - December 2017 Quarter
Later from Invion
- Photosoft efficiently destroys ovarian cancer cells in vitro
- Appendix 4C - June 2018 quarter
- Appendix 4E Annual Report and Full Year Statutory Accounts
- Spin out of respiratory assets for development in China
- New Photosoft formulation increased effect in ovarian cancer
Follow Invion into a list and get an email when it puts out news.
Follow Invion